Noble

Noble, an Aptar Pharma company, supplies onboarding and training devices, such as mechanical and smart, error correcting autoinjectors, prefilled syringes, on-body injectors, inhalers, angle aid tools, auditory packaging and other multisensory solutions, to pharma and biotech clients.

Associated Companies

Aptar Pharma Aptar Digital Health Gateway Analytical Nanopharm Next Breath

Headquarters
Noble International, Inc
121 South Orange Avenue
Suite 1070 North
Orlando
FL 32801
United States

Phone / Contact

T: +1 888 933 5646
E: [email protected]

Connect

Noble is a full-service, patient-centred product development and manufacturing company that specialises in providing medical device training solutions, patient onboarding strategies and multisensory product development for major global pharmaceutical brands and biotechnology companies.

Its training devices include mechanical and smart, error-correcting autoinjectors, prefilled syringes, on-body injectors, pulmonary delivery devices, angle-aid tools, auditory packaging and other multisensory solutions. Noble uses ISO 9001 and ISO 13485 supply chains and manufacturing facilities.

Noble was acquired by Aptar Pharma in November 2019. Prior to that it was privately owned, having been founded by Jeff and Hayley Baker in 1994, who were later joined by Craig Baker in 1997.

Articles by Noble

Benjamin D’hont

BUILDING DIGITAL SOLUTIONS TO MEET THE UNIQUE THERAPEUTIC NEEDS OF PATIENTS

Benjamin D’hont and Joe Reynolds discuss how the key to maturing the digital health market and increasing user retention of digital health apps is integrating agile app development from the beginning of a therapeutic’s development cycle.

HOW DIGITAL MEDICAL DEVICES ARE MEETING THE CHALLENGES OF CLINICAL TRIALS

Josh Hopkins discusses the challenges that have been present in conducting clinical trials at a central brick-and-mortar location since their inception, and how modern digitisation presents an opportunity to improve clinical trial methodology by liberating it from the need for an in-person central study site via the use of digital medical devices and technologies.

THE CRITICAL ROLE OF TRAINING IN THE USE OF NASAL RESCUE THERAPIES

Tim McLeroy discusses the role of nasally administered rescue treatments in preventing deaths from opioid overdose or misuse – highlighting the importance of training and treatment availability.

PLATFORM TRAINING SOLUTIONS ADD VALUE FOR PHARMACEUTICAL COMPANIES

Alex Catino discusses the unmet need in healthcare for proper patient onboarding and training in the field of prefilled syringes and injection devices. Ms Catino uses Noble’s training device for Ypsomed’s YpsoMate^® autoinjector as a case study for how bespoke training devices can be used to help improve the patient experience and adherence rates.

PREFILLED SYRINGES

TRAINING DEVICES & PATIENT EDUCATION PLAY A CRUCIAL ROLE IN THE SELF-INJECTION DRUG DELIVERY MARKET

Joe Reynolds discusses the role training devices and patient education play with regard to self-injection therapies.

PHARMA’S ROLE IN THE GLOBAL ENVIRONMENTAL SUSTAINABILITY MOVEMENT

Alex Catino discusses current trends in the pharmaceutical industry in relation to environmental sustainability in healthcare.

APPLYING CONNECTIVITY TO ENHANCE THE TRAINING STANDARD OF CARE FOR SELF-INJECTION

Erin Miller looks at how connectivity can be used to enhance training to help address the challenges of accuracy and non-adherence when patients self-inject their medications.

Bill Guilliouma

SUPPORTING IMPROVED PATIENT ONBOARDING & ADHERENCE WITH TRAINING SOLUTIONS

Bill Guilliouma looks at the role of platform training solutions for patient onboarding and adherence to treatment regimens.

Telemedicine gains acceptance amid the Covid-19 pandemic

Noble highlights how telemedicine is poised to become a mainstream alternative to the traditional in-person methods of care delivery, with the covid-19 pandemic easing barriers to acceptance and introducing patients to the safety and convenience of telehealth technology.

THE IMPORTANCE OF TRAINING AND ONBOARDING FOR INTRANASAL RESCUE THERAPIES

With a recent resurgence in nasal drug repurposing, Joe Masci looks at the importance of training and onboarding for intranasal rescue therapies.

Aptar Group Releases COVID-19 Update for its Customers and Partners

Aptar Pharma has released a message from its President and Chief Executive Officer to provide a COVID-19 update to inform its customers and partners of the measures the Group is taking in regards to the evolving coronavirus pandemic in order to continue to support our customers.

PREFILLED SYRINGES

ENHANCING THE PATIENT EXPERIENCE FOR SELF-INJECTION SYSTEMS

The complexity of injectable treatment regimens for chronic diseases means onboarding aids can be integral to disease management. Joe Reynolds discusses the role of demonstration devices in improving the patient experience and adherence.

PREFILLED SYRINGES

DEVELOPING DEMONSTRATORS TO INCREASE PATIENT CONFIDENCE AND REDUCE ANXIETY

Joe Reynolds discusses the value of demonstrators for making patients comfortable and effective with their prefilled syringe, leading to a significant improvement in treatment adherence and patient quality of life.

TRAINING PATIENTS IN THE USE OF WEARABLE INJECTORS

Joe Reynolds highlights the projected growth in popularity of wearable injector devices, and shows that it is imperative for healthcare providers (HCPs) both to train their patients properly in the office, and offer training devices that patients can take home and practice with.

ADHERENCE TO SELF-INJECTION REGIMENS CAN BE ENHANCED BY CONNECTED DEVICES

Craig Baker looks at the factors contributing to non-adherence and explores how connected devices can help patients follow their self-injection regimens.

TRAINING DEVICES INCREASE PATIENT ENGAGEMENT AND ADHERENCE – CREATING BETTER OUTCOMES

Erin Miller outlines a study looking at how patients interact with training resources during the first 14 days of a new treatment – and how training devices can help increase confidence, adherence and, ultimately, overall outcomes for the millions of patients who manage their diseases through self-injection.

BEST PRACTICES FOR DEVELOPING EFFECTIVE TRAINING DEVICES FOR PULMONARY HEALTHCARE

Joe Reynolds discusses the current state of pulmonary drug delivery device trainers, including their value to patients, the complexities of modern design and the stringent quality requirements.

PREFILLED SYRINGES

IMPROVING PATIENTS’ SELF-INJECTION EXPERIENCE

Jeff Lettman and Josh Hopkins explain how they worked with a client to develop a product that would function with the pre-existing drug delivery device to help rheumatoid arthritis patients with reduced dexterity.

DEVICE TRAINING AND ONBOARDING CONSIDERATIONS FOR ON-BODY DELIVERY SYSTEMS

Joe Reynolds explains how on-body injection devices have arisen from the need to develop viscous, large-volume biopharmaceutical therapies, and how Noble’s on-body training devices can help patients learn how to use their devices correctly, reliably and safely.

ENHANCING ADHERENCE TO SELF-INJECTION REGIMENS BY CONNECTED DEVICES

Craig Baker explains how Noble has recently launched the AdereIT platform for autoinjector training and injections to tackle the problem of non-adherence.

PREFILLED SYRINGES

AUTOINJECTOR TRAINER INNOVATIONS TO ENHANCE THE PATIENT EXPERIENCE

Joe Reynolds looks at the benefits offered by Noble's innovative agitator needle simulation tip – which can be incorporated into several types of autoinjector trainers – and reviews the development process.

REALISTIC PULMONARY DELIVERY SYSTEM TRAINERS

Craig Baker discusses the prevalence of improper use and how addressing this issue via training devices is of benefit to manufacturers, healthcare providers and patients.

PREFILLED SYRINGES

IMPROVING PATIENT EXPERIENCE WITH NEW ONBOARDING TECHNIQUES

Paul Sullivan outlines how the growing trend towards patient self-injection, outside of the clinical setting, places an ever greater emphasis on quality training and onboarding. Mr Sullivan specifically explains how such training can help overcome the issue of patient needle fear or anxiety.

DEVELOPING EFFECTIVE TRAINING DEVICES FOR THE PULMONARY HEALTHCARE MARKET

Pulmonary drug delivery is an effective route of pharmaceutical administration but research has shown that a large majority of patients fail to use their devices properly, training devices can help address this problem. Joe Reynolds looks at the design challenges that need to be addressed as well as some of the latest features that can be incorporated to develop optimal training devices for patients.

Top